Bellevue Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Sell
20,851
-22,904
-52% -$2.35M 0.04% 80
2025
Q4
$4.17M Buy
43,755
+9,800
+29% +$987K 0.08% 79
2025
Q3
$3.35M Sell
33,955
-1,084
-3% -$116K 0.07% 85
2025
Q2
$3.73M Buy
35,039
+27,075
+340% +$2.73M 0.08% 87
2025
Q1
$725K Sell
7,964
-368
-4% -$41.2K 0.02% 113
2024
Q4
$949K Sell
8,332
-389
-4% -$44.4K 0.02% 118
2024
Q3
$1.04M Buy
+8,721
New +$802K 0.02% 116
2023
Q2
Sell
-196,480
Closed -$24.5M 158
2023
Q1
$24.5M Sell
196,480
-24,600
-11% -$3.38M 0.36% 70
2022
Q4
$33.2M Buy
221,080
+67,500
+44% +$10.4M 0.44% 65
2022
Q3
$20.7M Buy
153,580
+2,380
+2% +$364K 0.3% 82
2022
Q2
$22.5M Buy
151,200
+39,434
+35% +$6.03M 0.32% 81
2022
Q1
$19.1M Sell
111,766
-1,700
-1% -$286K 0.22% 95
2021
Q4
$29.3M Buy
113,466
+100,766
+793% +$27.6M 0.3% 89
2021
Q3
$3.47M Sell
12,700
-9,900
-44% -$3.15M 0.04% 137
2021
Q2
$5.06M Sell
22,600
-22,900
-50% -$4.32M 0.05% 132
2021
Q1
$4.97M Buy
45,500
+27,500
+153% +$2.92M 0.05% 130
2020
Q4
$1.47M Sell
18,000
-31,500
-64% -$3.09M 0.02% 150
2020
Q3
$3.43M Sell
49,500
-500
-1% -$35.9K 0.05% 132
2020
Q2
$3.34M Buy
+50,000
New +$2.5M 0.05% 127

Other funds holding BNTX